Your session is about to expire
← Back to Search
Behavioural Intervention
Project EVO Multi- Treatment for Systemic Lupus Erythematosus
N/A
Waitlist Available
Research Sponsored by National Jewish Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of SLE
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
Study Summary
The purpose of this study is to evaluate whether a short interactive video game device is associated with performance on standard measures of attention and problem solving in patients with systemic lupus erythematosus(SLE). The study is also designed to see if playing the video game for four weeks improves attention and problem solving in patients with SLE.
Eligible Conditions
- Systemic Lupus Erythematosus
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Digit Symbol Substitution Scores
Change in Digit Vigilance Test Scores
Change in EVO performance threshold
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Project EVO Multi- TreatmentExperimental Treatment1 Intervention
Treatment group receives video game device treatment. Participant plays the game for 30 minutes a day, at least five days a week for four weeks.
Group II: ControlActive Control1 Intervention
No contact control
Find a Location
Who is running the clinical trial?
National Jewish HealthLead Sponsor
140 Previous Clinical Trials
316,176 Total Patients Enrolled
Akili Interactive Labs, Inc.Industry Sponsor
16 Previous Clinical Trials
5,605 Total Patients Enrolled
Novartis PharmaceuticalsIndustry Sponsor
2,863 Previous Clinical Trials
4,199,275 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger